Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Royalty Pharma
RPRX
|
$709M |
| 2 |
WIX.com
WIX
|
$282M |
| 3 |
Spotify
SPOT
|
$279M |
| 4 |
Mercado Libre
MELI
|
$249M |
| 5 |
Roblox
RBLX
|
$228M |
Top Sells
| 1 |
KE Holdings
BEKE
|
$298M |
| 2 |
CBRE Group
CBRE
|
$283M |
| 3 |
Tesla
TSLA
|
$275M |
| 4 |
Amazon
AMZN
|
$256M |
| 5 |
NVIDIA
NVDA
|
$237M |
Sector Composition
| 1 | Consumer Discretionary | 27.47% |
| 2 | Healthcare | 25.5% |
| 3 | Technology | 17.5% |
| 4 | Communication Services | 10.66% |
| 5 | Financials | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BZUN
201
Baozun
BZUN
$227M
| $16.1M | 0.02% |
1,470,264
-8,895
| -0.6% | -$97.3K |
|
202
Archer Daniels Midland
ADM
$29.9B
| $15.3M | 0.02% |
+196,835
| New | +$15.3M |
|
203
ResMed
RMD
$40.9B
| $15.2M | 0.02% |
72,559
-8,120
| -10% | -$1.7M |
|
204
EverQuote
EVER
$866M
| $12.2M | 0.01% |
1,377,326
+5,222
| +0.4% | +$46.2K |
|
205
Digimarc
DMRC
$186M
| $11.7M | 0.01% |
827,766
-3,638
| -0.4% | -$51.4K |
|
206
Masimo
MASI
$8.08B
| $11.7M | 0.01% |
89,472
-10,702
| -11% | -$1.4M |
|
207
Ionis Pharmaceuticals
IONS
$9.72B
| $11.5M | 0.01% |
311,015
-37,848
| -11% | -$1.4M |
|
208
Bumble
BMBL
$703M
| $11.3M | 0.01% |
400,000
| – | – |
|
209
Zillow
ZG
$21B
| $11M | 0.01% |
344,477
-2,884
| -0.8% | -$91.8K |
|
210
StoneCo
STNE
$4.62B
| $10.8M | 0.01% |
1,408,142
-86,952
| -6% | -$669K |
|
211
Visa
V
$664B
| $10.3M | 0.01% |
52,499
| – | – |
|
212
Quanterix
QTRX
$210M
| $10.2M | 0.01% |
630,870
-1,378
| -0.2% | -$22.3K |
|
213
TJX Companies
TJX
$157B
| $10.1M | 0.01% |
181,286
+73,855
| +69% | +$4.12M |
|
214
Sherwin-Williams
SHW
$93.6B
| $9.95M | 0.01% |
44,453
| – | – |
|
215
Cooper Companies
COO
$13.7B
| $9.82M | 0.01% |
125,492
| – | – |
|
216
Sutro Biopharma
STRO
$83.3M
| $9.72M | 0.01% |
1,865,180
-3,321
| -0.2% | -$17.3K |
|
217
NetEase
NTES
$91.2B
| $9.65M | 0.01% |
103,340
-160,012
| -61% | -$14.9M |
|
|
KDNY
218
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $8.83M | 0.01% |
504,825
-306,054
| -38% | -$5.35M |
|
219
XP
XP
$9.76B
| $8.22M | 0.01% |
457,944
+7,648
| +2% | +$137K |
|
220
Ascendis Pharma
ASND
$12.4B
| $7.98M | 0.01% |
85,800
-8,851
| -9% | -$823K |
|
221
Veeva Systems
VEEV
$46.3B
| $7.94M | 0.01% |
40,106
-4,549
| -10% | -$901K |
|
222
QuantumScape
QS
$5.37B
| $7.87M | 0.01% |
916,281
| – | – |
|
|
BNFT
223
DELISTED
Benefitfocus, Inc.
BNFT
| $7.76M | 0.01% |
996,785
+3,778
| +0.4% | +$29.4K |
|
224
American Superconductor
AMSC
$2.26B
| $7.73M | 0.01% |
1,491,370
| – | – |
|
225
Vimeo
VMEO
$774M
| $7.38M | 0.01% |
1,225,243
-6,075,953
| -83% | -$36.6M |
|